drugset / Trial / NCT00351611

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

NCT00351611

Phase 4 Completed 187 enrolled Viatris Inc.
RandomizedTriple-blindTreatment

Summary

Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.

Timeline

Start
2006-07-26
Primary completion
2020-02-04
Completion
2020-02-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg Oral

Indications